UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐
Check the appropriate box:
☐ | Preliminary Proxy Statement |
☐ | Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
☐ | Definitive Proxy Statement |
☒ | Definitive Additional Materials |
☐ | Soliciting Material Pursuant to § 240.14a-12 |
MANNKIND CORPORATION
(Name of Registrant as Specified in its Charter)
N/A
(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)
Payment of Filing Fee (Check the appropriate box):
☑ | No fee required. |
☐ | Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. |
(1) | Title of each class of securities to which transaction applies: |
(2) | Aggregate number of securities to which transaction applies: |
(3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): |
(4) | Proposed maximum aggregate value of transaction: |
(5) | Total fee paid: |
☐ | Fee paid previously with preliminary materials: |
☐ | Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. |
(1) | Amount previously paid: |
(2) | Form, Schedule or Registration Statement No.: |
(3) | Filing Party: |
(4) | Date Filed: |
MannKind Corporation |
Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting of Stockholders to be held on May 18, 2017 for MannKind Corporation
This communication is not a form of voting and presents only an overview of the more complete proxy materials that are available to you on the Internet. We encourage you to access and review all of the important information contained in the proxy materials before voting. To view the proxy statement, annual report, directions to the annual meeting and voting instructions, go to www.proxydocs.com/mnkd. To submit your proxy while visiting this site, you will need the 12 digit control number in the box below.
|
||||
|
View Proxy Materials and Annual Report Online at www.proxydocs.com/mnkd A convenient way to view proxy materials and VOTE! |
| ||
To view your proxy materials online, go to www.proxydocs.com/mnkd. Have the 12 digit control number available when you access the website and follow the instructions.
|
Proxy Materials Available to View or Receive:
1. Proxy Statement 2. Annual Report
Printed materials may be requested by one of the following methods:
You must use the 12 digit control number located in the shaded gray box below. |
* | If requesting materials by e-mail, please send a blank e-mail with the 12 digit control number (located below) in the subject line. No other requests, instructions or other inquiries should be included with your e-mail requesting materials. |
|
ACCOUNT NO. | SHARES |
MannKind Corporation Notice of Annual Meeting
Date: | May 18, 2017 | |||||
Time: | 10:00 A.M. (Eastern Daylight Time) | |||||
Place: | MannKind Corporation, 40 Taylor Street, Danbury, CT 06810 |
The purpose of the Annual Meeting is to take action on the following proposals:
Proposal 1 To elect the seven nominees named herein as directors to serve for the ensuing year and until their successors are elected;
01 Matthew J. Pfeffer | 04 Michael A. Friedman, MD | 07 Henry L. Nordhoff | ||
02 James S. Shannon, MD, MRCP (UK) | 05 Kent Kresa | |||
03 Ronald J. Consiglio | 06 David H. MacCallum |
Proposal 2 To approve, on an advisory basis, the compensation of the named executive officers of MannKind, as disclosed in MannKinds proxy statement for the Annual Meeting;
Proposal 3 To indicate, on an advisory basis, the preferred frequency of stockholder advisory vote on the compensation of the named executive officers of MannKind; and
Proposal 4 To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of MannKind for its fiscal year ending December 31, 2017.
The Board of Directors recommends that you vote FOR all nominees in proposal 1, one year for proposal 3, and FOR proposals 2 and 4.